Andrew is a qualified lawyer having practiced for nearly 20 years at a large commercial firm. Following his retirement from the law in 2006 he founded a renewable energy business which he sold to Origin Energy in 2009. Since that time he has been involved in a start-up property app business which he sold to ANZ in 2015 and various other businesses.
Andrew has been a director of numerous private companies and not-for-profit organizations and currently is a director of Supra Capital, a Commissioner of the AFL and a director of Golf Australia.
Joshua is the founder of Althea Group and has extensive experience in business building, sales and marketing. He has a range of proven business and strategy skills and previously held a number of senior management roles at national value-based retailer, Strathfield Group.
Joshua founded Althea Health and Wellbeing in 2016, coinciding with registration of the ND Amendment Act, an Act to amend the ND Act, legalizing medicinal cannabis.
Alan is the Chief Financial Officer and Company Secretary of Ridley Corporation Limited, an ASX-listed provider of high-performance animal nutrition solutions. Prior to this role, Alan occupied the same position with listed biotechnology companies Avexa Limited and Zenyth Therapeutics Limited, website pioneer Sausage Software Limited, and unlisted public entity HRL Limited, where he later served as a non-executive director and Chair of the Audit Committee.
Alan started his professional career in chartered accounting firms in England and Australia and has broad financial experience across many industry sectors.
Penny Dobson, is an experienced global healthcare executive and Non-Executive Director. She has worked in the broad life-sciences space since her training as a pharmacist in New Zealand, including many years in the global pharmaceutical industry. Penny is currently principal at Valida Consulting offering a range of services to companies in the healthcare, Pharma, Biotech, Not for Profits and Device and Diagnostic sector.
Previously, Penny spent many years with Merck and Company Inc and its subsidiaries MSD and Banyu Pharmaceuticals in Australia, New Zealand, the US and Japan. She was Vice President of MSD in Japan and leader of the integration of the Schering Plough acquisition in Japan.